Wen Chuan Zhou
Chief Executive Officer at MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED
Net worth: 603 948 $ as of 2024-03-30
Profile
Wen Chuan Zhou is currently the Vice Chairman & Chief Executive Officer at Meilleure Health International Industry Group Ltd.
She is also a Director at Gongniu Group Co., Ltd.
and Shenzhen Wingor Bio-technology Co., Ltd.
Ms. Zhou completed her undergraduate and graduate degrees at the University of British Columbia in 2007 and 2008 respectively.
She also obtained an MBA from The Chinese University of Hong Kong in 2011.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-27 | 31,938,000 ( 0.78% ) | 603 948 $ | 2024-03-30 |
Wen Chuan Zhou active positions
Companies | Position | Start |
---|---|---|
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED | Chief Executive Officer | 2008-12-31 |
GONGNIU GROUP CO.,LTD. | Director/Board Member | 2021-05-19 |
Shenzhen Wingor Bio-technology Co., Ltd.
Shenzhen Wingor Bio-technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China. | Director/Board Member | - |
Training of Wen Chuan Zhou
University of British Columbia | Graduate Degree |
The Chinese University of Hong Kong | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED | Distribution Services |
GONGNIU GROUP CO.,LTD. | Producer Manufacturing |
Private companies | 1 |
---|---|
Shenzhen Wingor Bio-technology Co., Ltd.
Shenzhen Wingor Bio-technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China. | Commercial Services |
- Stock Market
- Insiders
- Wen Chuan Zhou